
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Pliant Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Its lead product candidate, PLN-74809, is an oral small-molecule dual that helps in the treatment of idiopathic pulmonary fibrosis. Pliant Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Its lead product candidate, PLN-74809, is an oral small-molecule dual that helps in the treatment of idiopathic pulmonary fibrosis.
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.032656 | 2.00343558282 | 1.63 | 1.775 | 1.455 | 1832426 | 1.60536293 | CS |
4 | -1.397344 | -45.6648366013 | 3.06 | 3.46 | 1.26 | 3678804 | 1.99796734 | CS |
12 | -11.677344 | -87.5363118441 | 13.34 | 14.255 | 1.26 | 2584952 | 3.5094826 | CS |
26 | -10.997344 | -86.8668562401 | 12.66 | 16.1 | 1.26 | 1415146 | 5.46873645 | CS |
52 | -13.537344 | -89.0614736842 | 15.2 | 16.52 | 1.26 | 931077 | 7.300591 | CS |
156 | -6.337344 | -79.2168 | 8 | 36.64 | 1.26 | 812171 | 15.72585882 | CS |
260 | -20.837344 | -92.6104177778 | 22.5 | 43.92 | 1.26 | 556077 | 16.48131306 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions